Virtus Biotech ETF (BBP)

Assets	$77.81M
Expense Ratio	0.34%
PE Ratio	n/a
Shares Out	900,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	5,576
Open	85.74
Previous Close	86.61
Day's Range	84.71 - 86.25
52-Week Low	57.61
52-Week High	90.42
Beta	0.57
Holdings	62
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

27.54% of assets

Name	Symbol	Weight
ImmunityBio, Inc.	IBRX	4.96%
Iovance Biotherapeutics, Inc.	IOVA	3.20%
Moderna, Inc.	MRNA	2.81%
KalVista Pharmaceuticals, Inc.	KALV	2.56%
Axsome Therapeutics, Inc.	AXSM	2.51%
Novavax, Inc.	NVAX	2.49%
Legend Biotech Corporation	LEGN	2.46%
Mirum Pharmaceuticals, Inc.	MIRM	2.28%
Roivant Sciences Ltd.	ROIV	2.14%
Travere Therapeutics, Inc.	TVTX	2.13%

Performance

BBP had a total return of 44.74% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.85%.